CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
Prognostic Significance of Baseline Clinical and [68Ga]Ga-PSMA PET Derived Parameters on Biochemical Response, Overall Survival, and PSA Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoi…
DOI 10.1055/a-2365-8113
Bibliografische Angaben
Nachweis in CareLit
Autor:innenEsmail Jafari, Reyhaneh Manafi-Farid, Hojjat Ahmadzadehfar, Fatemeh Salek, Narges Jokar, Ahmad Keshavarz, GhasemAli Divband, Habibollah Dadgar, Farshad Zohrabi, Majid Assadi
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe06/2024
Jahrgang / SeitenJg. 63 · S. 347-358
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Background In this study, we sought to identify the clinical baseline characteristics and pre-therapy 68Ga-PSMA PET derived parameters that can have impact on PSA (biochemical) response, OS and PSA PFS in patients with metastatic castration-resistant prostate cancer (mCRPC) who undergo RLT with [177Lu]Lu-PSMA-617. Methods Various pre-treatment clinical and PSMA PET derived parameters were gathered and compu…
Zitieren
Zitierempfehlung
Esmail Jafari, Reyhaneh Manafi-Farid, Hojjat Ahmadzadehfar, Fatemeh Salek, Narges Jokar, Ahmad Keshavarz, GhasemAli Divband, Habibollah Dadgar, Farshad Zohrabi, Majid Assadi (2024) Prognostic Significance of Baseline Clinical and [68Ga]Ga-PSMA PET Derived Parameters on Biochemical Response, Overall Survival, and PSA Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Undergoing [177Lu]Lu-PSMA Therapy. Nuklearmedizin - NuclearMedicine, 63 (06), 347-358. https://doi.org/10.1055/a-2365-8113
Mit CareLit weiterarbeiten